Molecular basis of disturbed extracellular matrix homeostasis in stress cardiomyopathy

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1685-1688

  Szardien, Sebastian ^a   Möllmann, Helge ^a   Willmer, Matthias ^a   Liebetrau, Christoph ^a   Voss, Sandra ^a   Troidl, Christian ^a   Hoffmann, Jedrzej ^a   Rixe, Johannes ^a,b   Elsässer, Albrecht ^c   Hamm, Christian W ^a,b   Nef, Holger M ^a,b  

^a KERCKHOFF HEART CENTER   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c KLINIKUM OLDENBURG   (Germany)

Author keywords

Fibrosis; Stress; Takotsubo cardiomyopathy

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; VIMENTIN;

ACUTE DISEASE; CAPILLARY DENSITY; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELASTICITY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE COMPLIANCE; HEART MUSCLE FIBROSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LETTER; MICROCIRCULATION; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TAKOTSUBO CARDIOMYOPATHY;

FIBROSIS; STRESS; TAKOTSUBO CARDIOMYOPATHY;

EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMANS; TAKOTSUBO CARDIOMYOPATHY;

EID: 84885291561     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.075     Document Type: Article

References (19)

1. Nef HM, Mollmann H, Akashi YJ, Hamm CW. Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol Apr 2010;7(4):187-93.
2. Szardien S, Mollmann H, Elsasser A, Hamm CW, Nef HM. Historical and current pathoPhysiological concepts of stress (Tako-Tsubo) cardiomyopathy. Herz Jun 2010;35(4):258-64.
3. Nef HM, Mollmann H, Kostin S, et al. Tako-Tsubo cardiomyopathy: Intraindividual structural analysis In the acute phase and after functional recovery. Eur Heart J Oct 2007;28(20):2456-64.
4. Ueyama T. Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism. Ann N Y Acad Sci Jun 2004;1018:437-44.
5. Nef HM, Mollmann H, Troidl C, et al. Abnormalities In Intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy. Eur Heart J Sep 2009;30(17):2155-64.
6. Wei S, ChowLT, Shum IO, Qin L, Sanderson JE. Left and right ventricular collagen type I/iii ratios and remodeling post-myocardial Infarction. J Card Fail Jun 1999;5(2):117-26.
7. Roik M, Scislo P, Kochanowski J, Starczewska MH, Huczek Z, Opolski G. Tako-tsubolike transient left ventricular dysfunction-a newcause of diastolic heart failure. Int J Cardiol Jul 4 2008;127(2):e102-4.
8. van den Borne SW, Diez J, BlankesteijnWM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after Infarction: the role of myofibroblasts. Nat Rev Cardiol Jan 2010;7(1):30-7.
9. Lang C, Sauter M, Szalay G, et al. Connective tissue growth factor: a crucial cytokinemediating cardiac fibrosis In ongoing enterovirus myocarditis. J Mol Med Jan 2008;86(1):49-60.
10. Mori T, Kawara S, Shinozaki M, et al. Role and Interaction of connective tissue growth factor with transforming growth factor-beta In persistent fibrosis: a mouse fibrosis model. J Cell Physiol Oct 1999;181(1):153-9.
11. Kemp TJ, Aggeli IK, Sugden PH, Clerk A. Phenylephrine and endothelin-1 upregulate connective tissue growth factor In neonatal rat cardiac myocytes. J Mol Cell Cardiol Aug 2004;37(2):603-6.
12. Brigstock DR. Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals. J Cell Commun Signal Mar 2010;4(1):1-4.
13. Rolf A, Nef HM, Mollmann H, et al. Immunohistological basis of the late gadolinium enhancement phenomenon In tako-tsubo cardiomyopathy. Eur Heart J Jul 2009;30(13):1635-42.
14. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance In hypertrophic cardiomyopathy. J Am Coll Cardiol Jun 16 2004;43(12):2260-4.
15. Kurisu S, Inoue I, Kawagoe T, et al. Myocardial perfusion and fatty acidmetabolismin patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol Mar 5 2003;41(5):743-8.
16. Fazio G, Sarullo FM, Novo G, et al. Tako-tsubo cardiomyopathy and microCirculation. J Clin Monit Comput Apr 2010;24(2):101-500.
17. Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation Dec 16 2008;118(25):2754-62.
18. Li YY, McTiernan CF, Feldman AM. Interplay of matrix metalloproteinases, tissue Inhibitors of metalloproteinases and their regulators In cardiac matrix remodeling. Cardiovasc Res May 2000;46(2):214-24.
19. Butler GS, Apte SS, Willenbrock F, Murphy G. Human tissue Inhibitor of metalloproteinases 3 Interacts with both the N-and C-terminal domains of gelatinases A and B. Regulation by polyanions. J Biol Chem Apr 16 1999;274(16):10846-51.